We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Cutting Off Autoimmune Disease at the Checkpoint

News   Dec 03, 2018 | Original Story from Kanazawa University.

 
Cutting Off Autoimmune Disease at the Checkpoint

MHC class I and PD-L1 expression in the muscle tissue, as detected by immunohistochemistry. MHC class I and PD-L1 expression was upregulated in the sarcolemmal and sarcoplasmic regions in patients with myositis and myasthenia gravis. There was no overexpression of MHC class I and PD-L1 in muscle tissues obtained from patients with non-myopathy. Credit: Kanazawa University.

 
 
 

RELATED ARTICLES

Portable Ebola Test Brings Quicker Diagnosis to Remote Regions

News

Researchers have created a portable and fast-acting test that can distinguish Ebola infections from other fever-causing infectious diseases such as Lassa fever and malaria in around 30 minutes. Although further testing is required, this could be useful during febrile disease outbreaks.

READ MORE

Light Shed on Thallium Poisoning Cold Case by Mass Spectrometry

News

A mass spectrometry standardization method has been developed for generating a timeline of thallium poisoning by analyzing the victim’s hair.

READ MORE

Roots of Neuropsychiatric Risk in the Developing Brain

News

The most comprehensive genomic analysis of the human brain ever undertaken has revealed new insights into the changes it undergoes through development, how it varies among individuals, and the roots of neuropsychiatric illnesses such as autism spectrum disorders and schizophrenia.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Analysis & Separations Biopharma Cell Science Drug Discovery Genomics Research Immunology & Microbiology

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE